Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
Anti-PD1/PD-L1-directed immune checkpoint inhibitors are game changers in advanced non-small-cell lung cancer, but biomarkers are lacking. The aim of our study was to find clinically relevant biomarkers of the efficacy of ICI in non-squamous NSCLC. We conducted a retrospective study of patients rece...
Main Authors: | Loïck Galland, Anne Laure Le Page, Julie Lecuelle, Frederic Bibeau, Youssef Oulkhouir, Valentin Derangère, Caroline Truntzer, François Ghiringhelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2021.1957603 |
Similar Items
-
Sensitivity and prognostic value of thyroid transcription factor-1 and napsin A in primary adenocarcinoma of the lung
by: Patryk Kraiński, et al.
Published: (2020-01-01) -
Utility of immunohistochemistry method in expression of thyroid transcription factor-1 in endometrial and endocervical adenocarcinoma
by: Janbazvatan A, et al.
Published: (2011-02-01) -
TTF-1 Expression in Rectal Adenocarcinoma: A Case Report and Review of the Literature
by: Astrid Belalcazar, et al.
Published: (2016-11-01) -
Expression and Clinical Significance of the Thyroid Transcription Factor 1
in Xuanwei Lung Adenocarcinoma
by: Yunfen ZU, et al.
Published: (2013-03-01) -
Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations
by: Ji Young Park, et al.
Published: (2019-06-01)